Apmonia Therapeutics laureate from EIC accelerator program
stephanie.dhont2024-07-17T11:54:52+02:00Apmonia Therapeutics will receive €2.5 million in funding and €7 [...]
July 2024
May 2024
PR : MATWIN celebrates 15 years of innovation against cancer
stephanie.dhont2024-05-23T12:01:47+02:00Bordeaux, France, 2024 May 23 – Following the 9th edition [...]
HEPHAISTOS secures €10.3 M to reach the clinical stage
stephanie.dhont2024-05-22T14:40:24+02:00HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a [...]
March 2024
PR : Three new partners join forces with MATWIN to develop research and translational innovation in oncology
stephanie.dhont2024-03-11T10:27:58+01:00DOWNLOAD THE PRESS RELEASE
December 2023
PDC*line Pharma completes enrolment of four cohorts of patients in PDC-LUNG-101 phase I/II clinical trial
stephanie.dhont2023-12-06T15:54:43+01:00PDC*line Pharma, a clinical stage biotech company developing a new [...]
June 2023
In’CaRe: Call for projects in Oncology and Hematology
stephanie.dhont2023-06-27T09:30:48+02:00Cancers are still a major public health issue. Promoting innovation [...]
The Amgen France Fund for Science and Humans launches its 4th call for projects
stephanie.dhont2023-06-22T09:47:22+02:00Following the success of previous calls for projects, the Amgen [...]
Newsletter MATWIN June 2023
stephanie.dhont2023-06-12T14:33:52+02:00Download here the latest MATWIN newsletter :
MATWIN – PSCC partnership – Interview Benjamin Garel
stephanie.dhont2023-06-08T13:08:56+02:00Interview of Benjamin GAREL, General Manager of Paris Saclay Cancer [...]
MATWIN is hiring a R&D Project Manager (Oncology)
stephanie.dhont2023-06-08T13:10:05+02:00You dream of taking part in an exciting and meaningful [...]